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ABSTRACT 
We have developed a Lewis-acid catalyzed, diastereoselective aza-Cope rearrangement—
Mannich cyclization to form acyl pyrrolidines from conformationally mobile substrates. In 
earlier studies from our lab, Brønsted acid-catalyzed reactions to form the same acyl 
pyrrolidines resulted in diastereoselectivities of 8:1 trans to cis at elevated temperatures (60 
°C) over the course of 150 minutes. We have demonstrated an improvement in our method 
yielding exclusively the trans isomers at ambient temperature with substoichiometric 
amounts of BF3•OEt2 within 3 minutes. Catalyst loadings as low as 0.05 equivalents of 
BF3•OEt2 initiate this transformation. Our synthetic method employs the oxazolidine starting 
material as a mixture of diastereomers to produce one pyrrolidine diastereomer. Both ethyl- 
and substituted phenyl-oxazolidines were successfully rearranged. This work is the first 
example of a truly catalytic aza-Cope—Mannich reaction and provides the first examples of 
diastereoselective syntheses of 2-phenyl-4-acylpyrrolidines via this reaction.
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I.  Introduction 
Acyl pyrrolidine scaffolds are important structural motifs for a number of valuable 
pharmaceuticals and natural products.  The unnatural amino acid β-proline (1) is one of the 
least complex examples of this motif and is utilized in anti-selective Mannich reactions
1
 
(Figure 1). More functionalized pyrrolidines are used as target specific antibiotics such as 
anisomycin (2), an antifungal and amoebicide
2, 3
. Darifenacin (3), a commercially marketed 
drug, is an effective M₃ muscarinic receptor antagonist used to inhibit contractions that result 
in an overactive bladder. 
4
 
 
Figure 1. Novel targets employing acyl pyrrolidines as scaffolds 
As the activity of these compounds is highly dependent on both their absolute and 
relative stereochemistries, the development of a useful synthetic pathway to these targets 
hinges on the stereoselectivity of the method.  This has been a challenge in the past;
5,6
 
however, we have developed an efficient, diastereoselective synthetic pathway to acyl 
pyrrolidines from conformationally mobile systems.  
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II. Literature Review 
Our synthetic design employs the aza-Cope-rearrangement—Mannich cyclization of 
oxazolidines to acyl pyrrolidines, originally pioneered by Overman
7
. A mixture of 
oxazolidine diastereomers 4 is treated with a Lewis acid (Scheme 1). The acid coordination 
activates the ring, which ionizes to form iminium cation intermediate 5. Intermediate 5 then 
undergoes a 3,3-sigmatropic rearrangement to form iminium cation 6 followed by a ring 
closure to form acyl pyrrolidine diastereomers 7 and 8. 
Scheme 1 
 
A. Aza-Cope—Mannich vs aza-Prins—pinacol                                                                                 
There are two mechanistic pathways that could form an acyl pyrrolidine from an 
iminium cation:  the aforementioned aza-Cope rearrangement—Mannich cyclization and the 
aza-Prins—pinacol rearrangement could, in principle, produce the observed acyl pyrrolidines 
(Scheme 2).  The aza-Cope rearrangement begins when iminium cation A undergoes a 3,3-
sigmatropic rearrangement to form the second iminium cation B.  The Mannich cyclization 
occurs when the enol/enolate moiety of iminium cation B then cyclizes onto the carbon of the 
iminium cation B to form acyl pyrrolidine D.  For the aza-Prins pathway, once the iminium 
cation is formed the C-C double bond cyclizes onto the iminium cation to form piperidyl 
cation C. The carbocation then undergoes a pinacol rearrangement (a 1,2-alkyl shift along 
with formation of the carbonyl) to form acyl pyrrolidine D or piperidone E. 
 3 
 
Scheme 2 
 
Several investigators have sought to discern which mechanism is operating. Jacobsen, 
Levin, and Overman
8
 attempted to distinguish between the two by studying the reaction of 
enantioenriched oxazolidine 9 (Scheme 3) as well as incorporating electron withdrawing or 
donating substituents on the vinyl group of a cyclic-amino alcohol (vide infra). 
Scheme 3 
 
Enantioenriched oxazolidine 9 was treated with camphorsulphonic acid (CSA) for 1.5 
hours at 60 ºC (Scheme 3).  The enantiomeric excess for oxazolidine 9 was not reported, 
however the authors estimated the enantiopurity of the starting oxazolidine 9 to be greater 
 4 
 
than 90% by NMR analysis of a Mosher amide derived from the oxazolidine prior to its N-
methylation.  Chromatography and recrystallization yielded a single diastereomer 10 that was 
found to be racemic.  From this racemization, the authors concluded that the aza-Cope—
Mannich (ACM) mechanism was operating rather than the aza-Prins—pinacol.  It was argued 
by the authors that racemization in the ACM could be expected if the reaction proceeded 
through an achiral intermediate and if C-C bond rotation occurred prior to the Mannich 
cyclization (Scheme 4, G → H).  Furthermore, racemization could not occur in the aza-
Prins—pinacol (E → F → 10) because intermediate F would maintain chirality during ring 
formation.  
Scheme 4 
 
Overman also made chemical modifications to the substrate that produced evidence 
of an aza-Cope—Mannich mechanism8.  For this study, the location of the functional group 
probe was set to the position of the carbocation that would be formed in an aza-Prins 
mechanism (13, Scheme 5). By placing a strong electron withdrawing substituent in this 
position the carbocation would become destabilized which would likely slow the aza-Prins 
 5 
 
reaction. By contrast, a substituent at this position would have less effect on an aza-Cope 
reaction (11, Scheme 5). It is important to point out that this study was conducted under the 
assumption that the aza-Cope/aza-Prins is the rate determining step of the reaction.  
Scheme 5 
 
Overman observed that the reaction went to completion for all substrates with the 
exception of the sulfonyl-substituted substrate (Entry 7, Table 1). After subjecting the amino 
alcohol to 1.1 eq. AgNO3 in ethanol at room temperature, they isolated pyrrolidine 15a and 
the oxazolidine 15b in 20% and 40% yields respectively. They then attempted to increase the 
yield of 15a with the use of silver triflate (Entry 8) only to isolate the oxazolidine 
intermediate 15b. The unsubstituted amino alcohol also required heat and extended reaction 
time to reach completion (Entry 3). When run using conditions analogous to other successful 
reactions, epimerization at the α-position occurred (yield not reported, Entry 2).  The methyl 
and thioether-substituted amino alcohols gave the highest yield (Entries 1 and 4).   
 6 
 
  
 
Table 1. Electronic effects on the rearrangement of amino alcohol 14 to pyrrolidine 15a 
 
When the ethoxy-substituted amino alcohol was treated with 1.1 eq AgNO3 in ethanol 
at room temperature, nucleophilic trapping of the solvent occurred to give perhydroquinoline 
15d (Entry 5).  Formation of this product requires that the amino alcohol convert to the aza-
Prins intermediate 15c through an iminium ion-alkene cyclization (Scheme 6). 
Scheme 6 
 
 7 
 
Attempts were made to initiate pinacol rearrangement of 15d to 15a with both acidic 
and basic conditions. However, hydrolysis to the corresponding ketone rendered these 
attempts unsuccessful. When treated with silver triflate in ether the ethoxy-substituted amino 
alcohol converted to a complex mix of products. After purification 15a was isolated in 37% 
yield (Entry 6, Table 1).  
A similar study was conducted by Armstrong and Shanahan
9
 in their approach to 7-
azabicyclo[2.2.1]heptanes (Table 2). They screened several acids and found that 1 equivalent 
of SnCl4 initiated the rearrangement of N-tosyl protected α-alkoxy-pyrrolidines to 7-
azabicyclo[2.2.1]heptane 17. When 2 equivalents of SnCl4 were used, the product underwent 
a ring expansion to the [3.2.1]tropanone 18. To differentiate between aza-Cope and aza-Prins 
pathways the investigators used electron donating or withdrawing substituents on the same 
internal carbon of the vinyl group, as was the case in Overman’s investigation, to probe rate 
changes. 
 
 8 
 
 
Table 2. Electronic effects on intramolecular cyclization to form a bicyclic system. 
 
Two of the electron donating substituents (Entries 1 and 2, Table 2) gave good 
yields in the eight minute time period as would be expected; however the unsubstituted 
(Entry 3) and cyclohexenyl-substituted (Entry 6) substrates gave moderate to low yields.  
The quick reaction time and low yield of the electron donating thioether-substituted substrate 
(Entry 4) was due to the fact that the molecule very rapidly formed tropane 18, even in the 
presence of a single equivalent of SnCl4. The investigators also found that sulfonyl-
substituted amino alcohol resulted in cyclization to form oxazolidine 20 (Scheme 7). 
Overman had observed a similar conversion of a sulfonyl-substituted amino alcohol to 
oxazolidine prior to submitting it to CSA in refluxing benzene (cf. Table 1).   
 
 9 
 
Scheme 7 
 
It is curious that in both investigations, when submitted to the standard reaction 
conditions, the compounds with sulfonyl substituents rearrange to the oxazolidines 15b and 
20. Overman’s oxazolidine 15b was formed at room temperature within an hour after 
treatment with silver triflate at room temperature. Similarly, Armstrong et al. treated their 
starting material with SnCl4 at 0
 
ºC for 8 minutes and also isolated oxazolidine (20). Both 
unsubstituted compounds also displayed sluggish reaction times (Table 1, Entry 3 and 
Table 2, Entry 3). Overman’s reaction took 19 hours at 40 ºC to yield 64% of pyrrolidine 
15a.  Similarly, Armstrong et al. required 14.5 hours at 20 ºC to yield 32% of pyrrolidine 17.  
Both studies exhibited excellent yields for the methyl substituent as well (Table 1, Entry 1 
and Table 2, Entry 2). While the data reported in each publication is very similar, each 
author came to a different conclusion. Overman suggested that the aza-Cope—Mannich 
mechanism was operating while Armstrong suggested aza-Prins—pinacol as a rational for 
the products formed. In summary, these observations do not clearly differentiate between the 
aza-Cope and aza-Prins pathways across all systems. Overman confirmed the aza-Cope—
Mannich was in operation through the observed racemization of enantioenriched oxazolidine 
9. However, this did not necessarily translate to the bicyclic system, as evidenced by the 
isolation of the aza-Prins product (Entry 5, Table 1).   
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In systems without an allylic alcohol, the aza-Prins operates without pinacol 
rearrangement. Padrόn et al.10 found that tosylated iminium cation 21 (Scheme 8) yielded a 
mix of piperidine diastereomers 23 and 24 after nucleophilic addition of chloride ion onto the 
aza-Prins piperidyl cation intermediate 22.  
Scheme 8 
.   
What is striking about this halogen trapping is the fact that the nucleophile is introduced not 
just from the Lewis acid but from the solvent as well. The investigators formed this 
conclusion when they observed a mixture of bromo and chloro piperidines after FeBr3 was 
introduced as the Lewis acid in dichloromethane and also when FeCl3 was used in 
dibromomethane (Table 3).  This unique observation could be exploited in the future to 
distinguish between the aza-Prins and aza-Cope mechanisms. Should the halogen trapping of 
the piperidyl cation be faster than a pinacol reaction in systems with an allylic alcohol, the 
isolation of this side product would point to an aza-Prins pathway. However, the absence of 
this product cannot be a definitive marker for the aza-Cope pathway. 
  
 11 
 
 
 
Table 3. Halogen trapping of piperidyl cations by Lewis acid and solvent in systems without 
allylic alcohols. 
 
To date, no definitive studies have been published that distinguish between aza-
Cope—Mannich and aza-Prins—pinacol pathways.  The studies by both Overman and 
Armstrong rely heavily on the assumption that the aza-Cope/aza-Prins is the rate determining 
step of the reaction.  Overman asserts that the racemization of pyrrolidine from 
enantioenriched starting material requires the transformation through an achiral intermediate 
as well as C-C bond rotation prior to Mannich cyclization. This racemization would not be 
observed in an aza-Prins rearrangement due to the inability of C-C bond rotation to occur 
after ring formation.  Armstrong relies heavily on the absence of rearrangement in the case of 
the sulfonyl group as evidence of the aza-Prins pathway. It is possible that the aza-Prins may 
be discerned by halogen trapping from Lewis acid and solvent; however, as stated before the 
absence of this product cannot lead to a final conclusion. From the subsequent studies it is 
apparent that rearrangement is highly acid dependent. The evidence previously presented to 
differentiate between both mechanisms is largely inconclusive. 
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B.   Aza-Cope—Mannich reaction of small, conformationally mobile systems  
Several attempts have been made to optimize selectivity of the aza-Cope—Mannich 
in small, conformationally mobile systems. Historically, variations of this reaction have 
exhibited excellent stereocontrol in large, rigid systems
11,12
. However, in smaller 
conformationally mobile systems erosion of that control can occur through C-C bond 
rotations prior to or following the aza-Cope rearrangement or from acid-catalyzed 
epimerization of the products.   
In 1983 Overman, Kakimoto, Okazaki and Meier
5
 synthesized a variety of substituted 
4-acylpyrrolidines. The reactions were initiated by condensing 2-methoxy-(or hydroxy)-2-
methyl-3-butenamine 29 or ammonium salt 30 with an aldehyde in refluxing benzene or 
toluene (Scheme 9). Two procedures were developed to produce the final product. Either the 
tetrafluoroborate salt of the amine was directly condensed with the aldehyde, or the free 
amine was condensed with the aldehyde along with 0.9 equivalents of CSA to yield acyl 
pyrrolidine 31.  
Scheme 9 
 
 
 13 
 
In only one case were the investigators able to achieve a high yield with 0.1 
equivalents of acid. The reaction supports a variety of substituents with good yields; 
however, their reaction was limited to reactive, unhindered aldehydes (Entries 1-4, Table 4) 
and amino ethers. Less reactive aldehydes and ketones such as pivaldehyde, cyclohexanone 
and 3-pentanone (Entries 6-12) required the isolation of the oxazolidine intermediate 33 in 
order to form the desired product.  Reactions using cylododecanone (Entry 11) and 3-
pentanone (Entry 12) presented the poorest yields.  For the synthesis of 2-phenyl-pyrrolidine 
(Entry 5) the diastereoselectivity was reported as 2:1, however the major isomer was not 
identified.   
 
Table 4. Demonstration of the scope of the aza-Cope—Mannich reaction to produce 2-alkyl-
4-acetylpyrrolidines 
 
 14 
 
Cooke, Bennett, and McDaid
6
 were able to expand on this research by adding 
glyoxylic acid to α,β-amino allylic alcohol 35 (Scheme 10). The glyoxylic acid acts as both a 
substituent and a Brønsted acid. The reaction conditions are mild, and no purification other 
than rotary evaporation of the solvent was required to give 36 with an overall yield of 64%. 
The major diastereomer observed was the trans isomer, which was confirmed with NOE 
analysis. Unfortunately this diastereoselectivity was inconsistent and the trans to cis ratio 
ranged from 4:1 – 24:1. However, the reaction conditions that generated these variations 
were not specified.     
Scheme 10 
 
In 1994 Deng and Overman
13
 explored these losses, and mapped them on their way to 
a total synthesis of preussin. The initial strategy was to form the enantio-pure pyrrolidine 40 
by chirality transfer from (S)-phenylalanine and selective iminium cation formation (Scheme 
11). 
 15 
 
Scheme 11 
 
Table 5. A stereoselective example of cis acyl pyrrolidines in the total synthesis of preussin. 
When N-methyl oxazolidine 39 was refluxed in trifluoroacetic acid (TFA), a mix of 
diastereomers 40 and 41 was formed (Entry 1, Table 5).  However, when a similar 2º amine 
was subjected to 0.9 equivalents of CSA in trifluoroethanol at room temperature for 40 hours, 
only cis pyrrolidine 42 was obtained.  The selectivity for pyrrolidine 40 improves slightly 
with the addition of a benzyl-substituted oxazolidine (Entries 3 and 4). However, the overall 
diastereoselectivity of the N-alkylated series is variable, whereas the 2º amine gives excellent 
cis selectivity. 
In a previous publication
14
, we attempted a microwave-assisted, one-pot aza-Cope—
Mannich reaction. Allylic amino alcohol 43 (Table 6) was treated with aldehyde, CSA and 
 16 
 
copper sulfate to synthesize pyrrolidines 44a and 44b in good yields.  Our own attempts to 
utilize ethyl glyoxylate resulted in limited selectivity of 5:1 favoring the trans pyrrolidine, 
somewhat consistent with Cooke et al.’s 4:1-24:1 selectivity (Entry 9).  We observed 
improved trans selectivities of 5:1-8:1 with benzhydryl as the R1 substituent regardless of the 
R2 substituent (Entries 4, 5 and 11).  We surmised that the sterics of the R1 N-protecting 
group forms allylic strain with the R2 substituent, overcoming the 1,3 diaxial interactions, 
favoring a trans pyrrolidine F (Scheme 12). We had observed in some cases that lowering 
the temperature with increased reaction times lead to improved selectivities (Entries 4 and 5, 
7 and 8, 10 and 11).  An unpublished result (Entry 12) showed that at room temperature 
selectivity increased from 8:1 to 13:1. 
Scheme 12 
 
 17 
 
 
Table 6. Modest diastereoselectivity in a microwave assisted aza-Cope—Mannich formation 
of acyl pyrrolidines.  
 
  More recently, Padrόn15 and associates were able achieve excellent selectivity with a 
similar substrate utilizing FeCl3 at room temperature with 15 minute reaction times (Scheme 
13). With their tosyl-protected amino alcohol, they were able to achieve 99:1 trans to cis 
selectivity using a full equivalent of FeCl3 (Entries 1, 5-8, Table 7).  With substoichiometric 
amounts of FeCl3 they were able to achieve comparable selectivities (Entries 2, 4, 9 and 12). 
Unfortunately, when 0.1 molar equivalent of FeCl3 was used, an additional full equivalent of 
trimethylsilyl chloride (TMS-Cl) was required to recycle the catalyst. 
 
 
 18 
 
Scheme 13 
 
 The selectivity for the trans isomer in this system can be rationalized as in the 
previous case (Scheme 12).  The major disadvantage to using these conditions is the fact that 
the tosyl moiety prohibits aryl substituted-oxazolidines from reacting.  In the case of a phenyl 
substituent, no pyrrolidine product was observed, even with a full equivalent of FeCl3 
(Entries 11 and 12).  
 19 
 
 
Table 7. Aza-Cope—Mannich reactions using stoichiometric and substoichiometric FeCl3 
 
These previous attempts at a diastereoselective pyrrolidine synthesis have exhibited 
several limitations.  Cooke et al. was able to achieve excellent diastereoselectivity in some 
cases, but with limited reproducibility within the same system. In this report, only a single 
aldehyde substituent was used, but the novelty of this study is that it also acted as the 
activating acid
6
.  Overman was able to achieve rearrangement with large bulky ketones, 
albeit with minimal selectivity
5
.  Conditions required almost a full equivalent of acid, high 
temperatures and 24 hour reaction times.  Our own attempts yielded modest selectivities, 
requiring an equivalent of Brønsted acid, as well as half an equivalent of copper sulfate and 
 20 
 
longer reaction times
14
. Deng and Overman illustrated the importance of steric interactions 
with the N-protecting group to control diastereoselectivity
13
.  This was further supported by 
our own results when using the bulky benzhydryl moiety.  This was again verified by Padrόn 
et al. with the use of the large tosyl group, however the electronics of the tosyl moiety limited 
the substituents to alkyl groups, preventing aryl substituents at the C-2 position
15
.  Though 
Padrόn was able to demonstrate catalytic amounts of Lewis acid to be successful, these 
conditions required an additional equivalent of TMS-Cl to initiate catalyst turnover.   
III. Results and Discussion 
In light of the literature it is important to keep in mind that both aza-Cope—Mannich 
and aza-Prins—pinacol pathways are possible.  For our substrates, we cannot determine that 
one mechanism is operating over the other.  Nonetheless, the aza-Cope—Mannich is the 
reaction that has typically been used to describe transformations that are similar to our own
5-
8, 12-16
.  Thus these results are presented in the context of the aza-Cope—Mannich reaction.    
A. Carbon-carbon bond rotation causes loss of stereochemistry  
In an open, chair-like transition state, stereoselectivity may be lost through C-C bond 
rotation (Scheme 14).  Bond rotation may occur before or after the aza-Cope rearrangement. 
If chair A undergoes ACM without rotation the acyl pyrrolidine II is formed.  A bond 
rotation may convert the chair A to boat B resulting in the cis acyl pyrrolidine III. Similarly, 
three bond rotations can convert chair A to chair B, which would form the ent-trans acyl 
pyrrolidine IV.  Finally a post aza-Cope bond rotation, for example to boat A or chair C, 
would result in the ent-cis acyl pyrrolidine I.    
 
 
 
 
 21 
 
Scheme 14 
 
 
 
 
 
 
 
 
Selectivity may also erode through iminium cation isomerization. To mitigate this, 
use of an appropriate protecting group may favor one diastereomer over another (Scheme 
15). The energy difference between iminium cation intermediates may be increased through 
the manipulation of the allylic and 1,3 diaxial interactions of the amine protecting group with 
the iminium cation substituent
16
. In the presence of a bulky substituent and a large protecting 
group, a lower energy reactive conformation may be achieved through formation of chair D, 
which will lead to trans pyrrolidine F after ACM.  If a small protecting group is employed, 
the 1,3 diaxial strain between the substituents overcomes the allylic interactions of the 
protecting group and the adjacent substituent in the pseudo-equatorial position. Chair A is 
then favored as the reactive conformation, leading to the cis pyrrolidine C. For the purpose of 
this project we sought to apply these principles of iminium cation selectivity to synthesis of 
 22 
 
2-ethyl and 2-phenyl acetyl pyrrolidines. To date, only a single synthesis of a 2-phenyl acetyl 
pyrrolidine has been reported
5
.  However, the diastereoselectivity in this case was very poor 
(cf. Table 4, Entry 5).  
Scheme 15
  
B. Discovery of a catalytic aza-Cope—Mannich  
We began by synthesizing 2-ethyl-substituted N-benzhydryl oxazolidine 47 (Table 8)   
by microwave-assisted condensation of the appropriate allylic amino alcohol and aldehyde in 
the presence of 3Å molecular sieves. After chromatography, oxazolidine 47 was isolated as a 
1.6:1 mix of diastereomers. Previously, we had screened several Lewis acids and found 
BF3•OEt2 to give the best yields in our earlier systems.  We found that we were able to 
successfully perform the reaction with a full equivalent of Lewis acid (Entry 1) in 15 
minutes to generate 48a in good yield.  We attempted the reaction with 0.25 equivalents of 
acid and observed the same result (Entry 2). We then used only 0.1 equivalents of acid 
(Entry 3); however, we only observed 15% conversion of oxazolidine 47 to pyrrolidine 48a.  
It should be noted that where >50:1 selectivity is indicated, no cis isomer was detected by 
1
H 
NMR.   
 23 
 
 
Table 8. Optimization of the Lewis acid catalyzed aza-Cope—Mannich reaction in the 
synthesis of 2-ethyl acetyl pyrrolidine.   
 
Having established an optimal catalyst loading of 0.25 equivalents of acid with the 
ethyl-substituted oxazolidine 47, we attempted the same reaction with 2-phenyl-substituted 
N-benzhydryl oxazolidine 49, which was present as a 1.71:1 mix of diastereomers (Table 9).  
We subjected the mixture of oxazolidine diastereomers to a full equivalent of BF3•OEt2 and 
allowed the reaction to proceed for 1 hour (Entry 1, Table 9).  To our delight the reaction 
went to completion and yielded a single isomer, the first example of stereoselective aza-
Cope—Mannich to generate a 2-aryl-4-acyl pyrrolidine.  We then performed the reaction 
with 0.25 equivalent of BF3•OEt2 for 1 hour and found the same result.  We also attempted 
the use of 0.1 equivalent of BF3•OEt2 for 1 hour and found that the reaction went to 
completion (Entry 3). To our knowledge, this is the first example of a catalytic, 
diastereoselective aza-Cope—Mannich reaction. Once we had optimized the Lewis acid 
catalyst loading, we began to test the rate of reaction. We found that we could perform the 
reaction in 3 minutes with 0.25 equivalents of acid (Entry 2).  We observed the reaction by 
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NMR and found that the reaction was complete in 7 minutes using 0.05 equivalents of acid 
(Entry 4).      
 
Table 9. Optimization and discovery of a catalytic aza-Cope—Mannich pathway to 2-aryl 
pyrrolidines.   
 
C. Investigation of electronic effects on the aza-Cope—Mannich reaction   
In light of these results, we wanted to determine why the ethyl-substituted 
oxazolidine converted very slowly with 0.1 equivalents of catalyst (Entry 3, Table 8) while 
the phenyl-substituted oxazolidine converted faster with that catalyst loading and with even 
less catalyst (Entries 3 and 4, Table 9). In order to explore the scope of these findings, we 
set out to perform a kinetic study to ascertain the reasons for these rate differences.  
Unpublished computational studies
17
 of similar N-alkyl protected systems have shown that 
the aza-Cope rearrangement is the rate determining step of the ACM sequence.  We set out to 
observe this experimentally by synthesizing a number of substituted aryl oxazolidines to 
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submit to our optimized conditions (0.25 equivalents of BF3•OEt2 in 0.5M CH2Cl2 at ambient 
temperatures). 
Substitution at the para position demonstrates resonance effects, whereas substitution 
at the meta position demonstrates inductive effects (Table 10).  When the acid activates the 
ring, iminium cation B is formed.  The sp
3
 carbon between the oxygen and nitrogen of 
oxazolidine A would be expected to exhibit a strong partial positive charge leading toward a 
formal cation in the transition state.  The unsubstituted aryl group would stabilize this by an 
electron donating inductive effect. Should the iminium cation formation be the rate 
determining step of the reaction, electron withdrawing substituents (Entries 2, 4-8) will act 
to increase the speed of reaction through inductive destabilization of the reactive sp
3
 carbon 
center. By contrast, the electron donating methoxy- and methyl-substituted aryl groups could 
stabilize the electron deficient carbon, thereby slowing the reaction.    
  
Table 10.  Predictions on the electronic and inductive effects of substituents on the rates of 
iminium cation formation, aza-Cope rearrangement and Mannich cyclization. 
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If the aza-Cope rearrangement is the rate determining step, we predict that electron 
donating substituents (Entries 2,4-8) will act to stabilize iminium cation B (Table 10) 
resulting in a decrease in the rate of reaction. Resonance withdrawing substituents will act to 
destabilize the iminium cation B which will act to increase the rate of the 3,3 sigmatropic 
shift and consequently the overall rate of reaction. If the Mannich cyclization is the rate 
determining step then there should be no appreciable change in rate as the iminium cation C 
results in a partial positive charge too far away to be significantly affected by the electronic 
effects of either meta or para substituents.   
With predictions in mind, we began our study by synthesizing the necessary 
oxazolidine intermediates via a microwave-assisted synthesis (Table 11). Those oxazolidines 
with a resonance electron donating methoxy substituent (61) and inductive electron donating 
methyl substituents (63 and 64) required longer reaction times.  By contrast, those containing 
electron withdrawing substituents (66 – 69) required significantly shorter reaction times. 
Early on, we encountered some decomposition of some of the oxazolidines during silica gel 
chromatography.  This could be suppressed by adding 1% triethylamine to the 
chromatography solvent system (Entries 4-7, Table 11, see experimental section for details).   
In addition, in some cases, co-elution of unreacted aldehyde with the oxazolidine during 
column chromatographic separations required the addition of NaBH4 to the reaction mixture.  
Resulting reduction of the aldehyde to the corresponding alcohol increased differences in 
retention times and facilitated successful separations (Entries 3-7, Table 11, see 
experimental section for details).   
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Table 11. Optimization of microwave assisted synthesis of oxazolidine intermediates from 
amino alcohol
18
. 
 
We subjected each mixture of oxazolidine diastereomers to 0.25 equivalents of 
BF3•OEt2 for 12 hours in order to ascertain if pyrrolidine selectivity was maintained in all 
systems (Table 12).  Curious results occurred with the introduction of the electron 
withdrawing nitro group at both the para and meta positions (Entries 7 and 8).  Selectivity 
degraded somewhat from >50:1 favoring trans to cis to a ratio of 18:1.  As noted earlier, 
where >50:1 selectivity is indicated, no cis isomer was detected by 
1
H NMR (Entries 1-4, 6 
and 9).  Similarly, the introduction of the para-chloro substituent in oxazolidine 74 also 
degraded selectivity, but marginally to 36:1 (Entry 5).  Surprisingly, the same reduction in 
selectivity was not observed for the meta-chloro substituted pyrrolidine 75.   
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Table 12.  Diastereoselectivity in the formation of acyl pyrrolidines substituted with aryl 
groups of varying electronic demand. 
 
In addition to pre and post aza-Cope C-C bond rotation, stereoselectivity may erode 
through epimerization after Mannich cyclization. There are two possible ways for 
epimerization to occur once the Lewis acid has coordinated to the carbonyl of the pyrrolidine 
(Scheme 16).  The first is a retro-Mannich opening of pyrrolidine A to iminium cation B.  
Once the ring has opened it may either undergo C-C bond rotation and cyclize to form a 
mixture of pyrrolidine diastereomers A and E. It may also continue to revert through the aza-
Cope rearrangement C, undergo C-C bond rotation and proceed back through the aza-
Cope—Mannich to form E.  The second way for epimerization to occur is through keto/enol 
tautomerism of the ketone.  Once the Lewis acid coordinates to A, deprotonation of the 
adjacent hydrogen can occur, leading the enolate intermediate D.  Addition of the hydrogen 
may occur on either face, again leading to a mix of diastereomers A and E.   
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Scheme 16 
 
Throughout our studies, we observed variability in selectivity of the para-nitro 
substituted system with respect to time (Table 13).  It is possible that due to the reversibility 
of the Mannich cyclization, we are observing epimerization via one of the pathways 
described above (Scheme 16). When we allowed the reaction to proceed for 15-17 hours, 
trans to cis selectivity of 76a:76b ranged from 15:1-21:1 (Entries1-3, Table 13).  The two 
trials that ran for 12 hours varied quite a bit, with selectivities of 20:1 and 12:1 (Entries 4 
and 5).  Trials run between 25 minutes and 1 hour ranged from 8:1 to 10:1 (Entries 6-8).  We 
ran one trial reacting 5 vessels in tandem that were quenched with sodium bicarbonate 
solution at varying time points up to 3 minutes (Entries 9-13).  From this trial it appears that 
trans selectivity was greatest within the first 3 minutes of reaction but at the expense of 
conversion.  However, the extent of consistency within this time frame is unknown since 
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these reactions were only run once.  With these results in mind, we recommend the reaction 
be terminated as soon as possible to yield the greatest selectivity.  
 
Table 13. Variability of diastereoselectivity with reaction time in the formation of p-nitro-
phenyl acyl pyrrolidine. 
 
In order to monitor reaction rates, we developed a kinetics experiment using the 
JEOL Delta software.  Reaction vessels were set up as described in the experimental section 
in the general procedure for the preparation of 1-(1-benzhydryl-5-(R)pyrrolidin-3-
yl)ethanones and an aliquot was transferred via cannula to a dried NMR tube under nitrogen 
atmosphere. The tube was transferred to the instrument and gradient shimmed.  Initial trials 
 31 
 
indicated very fast reaction times. In fact, many had gone to completion as soon as the first 
scan was taken.  We attempted to dilute our Lewis acid and introduce it directly to an NMR 
tube, bypassing the time required to transfer an aliquot to the tube.  This however was 
unsuccessful. We were able to monitor a few reactions, however we encountered 
reproducibility issues likely related to the incompatibility of our Lewis acid with humid lab 
conditions as well logistical issues related to the very fast speeds of reaction.  We then 
changed our method to a timed quench method.  Again, several reaction vessels were set up 
as described in the general procedures in the experimental section. All conditions were kept 
constant with time as the variable. The Lewis acid was introduced to the reaction vessel and 
each reaction mixture was quenched with saturated sodium bicarbonate after a reaction time 
of 1, 5, 30, 60 or 180 seconds. Despite these detailed, careful efforts, a high amount of 
variability was observed at each time point, which left us unable to draw any conclusions 
from the data we had accrued. To demonstrate these inconsistencies, in the case of the para-
toluene-substituted acyl pyrrolidine, the extent to which the reaction went to completion 
varied a great deal (Table 14).  In the first trial, we observed little to no rearrangement within 
5 seconds (Entries 1 and 2).  However, we saw a maximum conversion at 30 seconds (Entry 
3) and were disappointed to see no greater conversion after 3 minutes (Entry 5).  We 
attempted a second trial, but saw minimal conversion to product (Entry 2).  Again, at 30 
seconds (Entry 3) we saw higher conversion, but the results between trials after 3 minutes 
were completely different, and strangely, showed less conversion than reactions run for less 
time (Entry 5).  In the third trial we saw little conversion within 30 seconds (Entries 1-3). 
Adding to these inconsistencies, trial 3 showed almost complete conversion after 3 minutes. 
Many of these reactions had gone to completion within 3 minutes during studies using the 
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previous NMR method.  We would expect this to remain consistent; however, as seen in 
Entry 5 alone there is a large variability between reactions run for 3 minutes. 
 
Table 14:  Challenges with reproducibility: p-toluene-substituted oxazolidine conversion 
during implementation of the quenching method. 
 
Initially we attempted to dilute our reaction mixture in an effort to slow the reaction 
(Entries 1-3, Table 15).  However, the reaction showed at least 50% conversion within the 
first minute. We then attempted to cool the reaction to 0 °C (Entries 4-10). Within the first 
minute we had surpassed our target of less than 10% conversion. We then attempted to cool 
the reaction to -20 °C with dry ice and ethylene glycol (Entry 11) the reaction converted 
1.5% in ten minutes but never continued thereafter.   Dilution of the reaction mixture and 
cooling to -10 °C resulted in 4% conversion; this reaction also failed to proceed further after 
the first aliquot was taken (Entry 10).  Due to the high speed of reaction, and variability of 
results the kinetic study of the N-benzhydryl system was abandoned. 
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Table 15: Strategies to optimize conditions for kinetic studies of the aza-Cope—Mannich 
cyclization of an unsubstituted 2-phenyl-N-benzhydryl protected system. 
 
IV. Conclusion  
Through manipulation of an appropriate N-protecting group, we have developed a 
diastereoselective synthetic pathway to acyl pyrrolidines from conformationally mobile 
starting materials. In previous studies from our lab using similar N-benzhydryl intermediates 
we were able to achieve diastereoselectivities of 8:1 trans to cis at elevated temperatures (60 
°C) over the course of 150 minutes. In this work, we have demonstrated an improvement in 
our method, resulting in primarily trans isomers at ambient temperature with 
substoichiometric amounts of BF3•OEt2 within 3 minutes. Catalyst loadings as low as 0.05 
equivalents of BF3•OEt2 initiate this transformation. Our synthetic method employs the 
oxazolidine starting materials as mixtures of diastereomers to produce one pyrrolidine 
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diastereomer. Both ethyl- and a number of substituted phenyl- oxazolidines were successfully 
rearranged.  Significantly, this is the first example of a diastereoselective aza-Cope—
Mannich reaction to produce 2-aryl-4-acyl-pyrrolidines. 
Unfortunately, strongly electron deficient aryl substituents at the C2 position exhibit 
small reductions in diastereoselectivity.  A better understanding of the future challenges with 
respect to stereocontrol depends upon the relative rates of each step within the reaction 
sequence. In order to address these issues in our own smaller mobile systems, we had sought 
to elucidate the rate-determining step of the ACM through reaction of a series of oxazolidines 
bearing aromatic electron donating and withdrawing substituents.  However, due to the rapid 
rate of reaction for all these substrates, we were unable to adequately monitor this reaction by 
NMR or traditional quenching methods.  Several unsuccessful attempts were made to slow 
reaction progression by diluting the reaction mixtures as well as cooling reactions to sub-zero 
temperatures. In the future, slower reactions will be required to observe substituent effects at 
the C2 position in the aza-Cope—Mannich pathway.   
There is always the possibility that the aza-Prins—Pinacol mechanism is operating in 
the formation of the products we have observed. During our studies we did not observe 
nucleophilic trapping of a 6-membered intermediate that would indicate such a mechanism.  
However, the absence of this product cannot be considered conclusive evidence of an aza-
Cope mechanism.  Other factors could mitigate the isolation of a trapped piperidyl cation.  
For example, the pinacol rearrangement may be faster than trapping by an external 
nucleophile or a viable external nucleophile may not exist under our reaction conditions.  At 
any rate, if the aza-Prins—pinacol is the operating mechanism in systems with this particular 
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substitution pattern, the mechanism is insignificant to the synthetic utility of the reaction; 
both mechanisms would be expected to yield the same trans selective product.  
V. Experimental 
General procedures 
All commercially available compounds were purchased from Sigma-Aldrich, Alpha 
Aesar, or Strem Chemical Companies and used as received unless otherwise specified. 
Methylene chloride was distilled from calcium hydride. Boron trifluorido-diethyl etherate 
(BF3•OEt2)was distilled from calcium hydride.  Purification of compounds by flash 
chromatography was performed using silica gel (40-75 μm particle size, 60 Å pore size). 
TLC analyses were performed on silica gel 60 F254 plates (250 μm thickness). Microwave-
assisted reactions were performed using a CEM DiscoverTM reactor.  All 
1
H NMR and 
13
C 
NMR spectra were obtained on a 400 MHz JEOL ECX instrument and chemical shifts (δ) 
reported relative to residual solvent peak CHCl3. All NMR spectra were obtained at room 
temperature.  
General procedure for the preparation of 1-(1-benzhydryl-5-(R)pyrrolidin-3-
yl)ethanones:  All oxazolidines were dried over activated silica with distilled methylene 
chloride and concentrated to yield a clear oil prior to reaction.  To a flame-dried round 
bottom flask was added 3Å molecular sieves (150.0 mg) and oxazolidine (0.500 mmol).  
Under inert gas atmosphere, freshly distilled dichloromethane (4 mL) was added.  The 
solution was allowed to stir for one hour.  Freshly distilled BF3•OEt2 (0.0177 g, 0.125 mmol) 
was added using a gastight syringe and allowed to stir for 15-60 minutes.   The reaction was 
quenched with saturated sodium bicarbonate solution, extracted 3 times with 
dichloromethane, dried over MgSO4 and concentrated. 
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General conditions for kinetic studies by 
1
H NMR: JEOL Delta software was set to 
monitor the reaction in non-deuterated methylene chloride with a gain value of 14-16. The X 
offset was 2 ppm with an X sweep range of 6ppm.  The X angle was set to 45°. A total of 
2048 points were scanned at 4 scans/15 seconds with a relaxation delay of 1s. Two hundred 
and forty time points were collected to yield a total collection time of 61:18 minutes.  
3-benzhydryl-5-methyl-2-ethyl-5-vinyloxazolidine [47]  
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (750 mg, 2.81 mmol) and propionaldehyde (163 mg, 2.81 
mmol). The vial was sealed with a reusable cap and then placed into the microwave reactor.  
The reaction was carried out with the following input parameters: 300 watts, 200 psi, and 125 
°C with a 1 minute ramp time and a hold time of 180 minutes. The crude product was 
purified via flash column chromatography using hexanes/ethyl acetate (90:10, v/v) to afford 
the title compound as a clear, pale yellow oil. 1.91:1 ds (576 mg, 67%). (Major) 
1
H NMR 
(400MHz, CDCl3) δ=0.86-0.80 (m, 3H), 1.34 (s, 3H), 2.98-2.95 (d, J=11.45 Hz, 1H), 3.08-
3.05 (d,J=11.45 Hz, 1H), 4.50-4.47 (dd, J=4.12 Hz, 5.95 Hz, 2H), 4.96 (s, 1H), 5.06-5.03 (dd, 
J=1.37 Hz, 10.99 Hz, 1H), 5.29-5.24 (dd, J=1.37 Hz,17.40 Hz, 1H), 5.29 (s, 1H), 5.95-5.91 
(dd, J=17.40 Hz, 10.99 Hz, 1H), 7.21-7.13 (m, 2H), 7.31-7.21 (m, 3H), 7.42-7.36 (m, 5H). 
(Minor) 
1
H NMR (400MHz, CDCl3) δ=0.86-0.81 (m, 3H), 1.34 (s, 3H), 2.62-2.59 (d, 
J=10.99 Hz, 1H), 3.08-3.05 (d, J=10.99 Hz, 1H), 4.44-4.42 (dd, J=3.66 Hz, 6.41 Hz, 2H), 
4.88 (s, 1H), 4.96 (s, 1H), 5.02-4.99 (dd, J=1.37 Hz, 10.53 Hz, 1H), 5.22-5.18 (dd, J=17.40 
Hz, 1.37 Hz, 1H), 6.05-6.00 (dd, J=10.99 Hz, 17.40 Hz, 1H), 7.21-7.13 (m, 2H), 7.31-7.21 
(m, 3H), 7.42-7.36 (m, 5H). 
13
C NMR (100MHz, CDCl3) δ= 9.97, 9.38, 25.44, 26.31, 26.97, 
28.06, 60.57, 70.55, 71.18, 79.94, 96.27, 96.86, 111.91, 112.12, 127.01, 127.16, 127.19, 
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128.03, 128.15, 128.39, 128.51, 128.55, 142.46, 143.27, 143.51, 142.59, 144.54 DART 
HRMS calcd for C21H25NO [M + H]
+
 307.19; found 308.20282 
3-benzhydryl-5-methyl-2-phenyl-5-vinyloxazolidine [49] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (130 mg, 0.487 mmol) and benzaldehyde (104 mg, 0.974 
mmol). The vial was sealed with a reusable cap and then placed into the microwave reactor.  
The reaction was carried out with the following input parameters: 300 watts, 200 psi, and 125 
°C with a 1 minute ramp time and a hold time of 15 minutes. The crude product was purified 
via flash column chromatography using hexanes/ethyl acetate/TEA (90:10:0.01, v/v) to 
afford the title compound as a clear, pale yellow oil. 1.71:1 ds (118 mg, 69%). (Major) 
1
H 
NMR (400MHz, CDCl3) δ=1.39 (s, 3H), 2.85-2.83 (d, J=10.53 Hz, 1H), 3.07-3.05 (d, 
J=10.53 Hz, 1H), 4.99 (s, 1H), 5.06-5.05 (d, J=11.34 Hz, 1H), 5.32-5.27 (d, J=19.23 Hz, 1H), 
5.29 (s, 1H), 6.01-5.94 (dd, J=17.86 Hz, 8.93 Hz, 1H), 7.15-7.05 (m, 5H), 7.37-7.21 (m, 7H), 
7.49-7.45 (m, 3H). (Minor) 
1
H NMR (400MHz, CDCl3) δ=1.34 (s, 3H), 2.54-2.51 (d, J=9.62 
Hz, 1H) 3.29-3.26 (d, J=9.62 Hz, 1H), 4.83 (s, 1H), 5.10-5.07 (dd, J=1.37 Hz, 11.91 Hz, 1H), 
5.26-5.22 (dd, J=1.37 Hz, 17.40 Hz, 1H), 5.29 (s, 1H), 6.14-6.07 (dd, J=10.99 Hz, 17.40 Hz, 
1H), 7.15-7.05 (m, 5H), 7.37-7.21 (m, 7H), 7.49-7.45 (m, 3H). 
13
C NMR (100MHz, CDCl3) 
δ=25.03, 26.56, 58.78, 59.43, 67.19, 68.81, 80.41, 81.02, 94.93, 95.19, 112.38, 112.50, 
126.84, 126.96, 127.23, 127.39, 127.85, 128.03, 128.07, 128.11, 128.18, 128.22, 128.38, 
128.48, 128.54, 128.58, 128.70, 129.28, 129.74, 139.81, 140.93, 141.622, 141.98, 141.98, 
142.49, 143.91. DART HRMS calcd for C25H25NO [M + H]
+
 355.19; found 356.20657 
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3-benzhydryl-5-methyl-2-(4-methoxyphenyl)-5-vinyloxazolidine [61] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (117 mg, 0.438 mmol) and p-anisaldehyde (119 mg, 
0.876 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude 
product was purified via flash column chromatography using hexanes/ethyl acetate (85:15, 
v/v) to afford the title compound as a clear, pale yellow oil. 1.57:1ds (114 mg, 68%). (Major) 
1
H NMR (400MHz, CDCl3) δ= 1.42 (s, 3H), 2.78-2.75 (d, J=10.53 Hz, 1H), 3.08-3.05 (d, 
J=10.53 Hz, 1H), 3.78 (s, 3H), 4.95 (s, 1H), 5.06-5.03 (dd, J=10.53 Hz, 1.37 Hz, 1H), 5.21 (s, 
1H), 5.29-5.24 (dd, J=17.40 Hz, 1.37 Hz, 1H), 5.99-5.92 (dd, J=17.40 Hz, 10.53 Hz, 1H), 
6.82-6.80 (m, 2H), 7.22-7.31 (m, 12H) (Minor) 
1
H NMR (400MHz, CDCl3) δ= 1.32 (s, 3H), 
2.49-2.47 (d, J=9.62 Hz, 1H), 3.28-3.25 (d, J=9.62 Hz, 1H), 3.78 (s, 3H), 4.82 (s, 1H), 5.06 
(s, 1H), 5.12-5.09 (dd, J=10.53 Hz, 1.37 Hz, 1H), 5.29-5.24 (dd, J=17.40 Hz, 1.37 Hz, 1H), 
6.17-6.10 (dd, J=17.40 Hz, 10.53 Hz, 1H), 6.82-6.80 (m, 2H), 7.22-7.31 (m, 12H). 
13
C NMR 
(100MHz, CDCl3) δ=25.43, 27.03, 53.10, 55.36, 57.69, 59.12, 66.10, 68.21,80.29, 80.72, 
94.25, 94.93, 112.42, 112.47, 113.63, 113.71, 126.91, 127.26, 127.42, 127.98, 128.02, 
128.20, 128.34, 128.38, 128.45, 128.91, 129.18, 129.50, 129.88, 130.15, 139.36, 141.15, 
142.02, 142.47, 143.76, 144.04, 159.68, 159.99. DART HRMS calcd for C26H27NO2 [M + 
H]
+ 
385.12; found 386.212004. 
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3-benzhydryl-5-methyl-2-(3-methoxyphenyl)-5-vinyloxazolidine [62] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (114 mg, 0.425 mmol) and m-anisaldehyde (116 mg, 
0.850 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude 
mixture was treated with sodium borohydride (16.0 mg, 0.425 mmol) and allowed to react 
for 20 minutes. The reaction was quenched with Amberlyst-21.  The crude mixture was then 
purified via flash column chromatography using hexanes/ethyl acetate (99:5, v/v) to afford 
the title compound as a clear, pale yellow oil. 1.94:1ds (116 mg, 71%). (Major)
 1
H NMR 
(400MHz, CDCl3) δ=1.38 (s,3H), 2.86-2.84 (d, J=10.53 Hz, 1H), 3.06 (d, J=10.53 Hz, 1H), 
3.77 (s, 3H), 5.01 (s, 1H), 5.08-5.05 (m, 1H), 5.32-5.28 (m,1H), 5.30 (s, 1H), 6.02-5.94 (dd, 
J=17.40 Hz, 10.99 Hz, 1H),6.78 (m, 2H), 7.45-7.04 (m, 12H) (Minor) 
1
H NMR (400MHz, 
CDCl3) δ=1.35 (s,3H), 2.55-2.52 (d, J=10.07 Hz, 1H), 3.29-3.26 (d, J=10.07 Hz, 1H), 3.75 (s, 
3H), 4.85 (s, 1H), 5.11-5.08 (m, 1H), 5.13, (s, 1H), 5.28-5.23 (m, 1H), 6.14-6.07 (dd, J=17.40 
Hz, 10.53 Hz, 1H), 7.45-7.04 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=26.06, 27.14, 55.27, 
58.76, 59.43, 67.31, 69.06, 80.74, 81.13, 94.73, 95.13, 112.29, 112.55, 112.21, 113.65, 
113.73, 114.48, 120.27, 121.06, 126.87, 127.02, 127.24, 127.42, 128.01, 128.06, 128.27, 
128.37, 128.41, 128.50, 128.68, 129.15, 129.18, 129.29, 130.15, 132.50, 137.71, 139.77, 
141.39, 141.68, 141.99, 142.64, 142.75, 143.90, 143.96. DART HRMS calcd for C26H27NO2 
[M + H]
+ 
385.12; found 386.21860 
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3-benzhydryl-5-methyl-2-(4-methylphenyl)-5-vinyloxazolidine [64] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (127 mg, 0.474 mmol) and p-tolualdehyde (114 mg, 
0.948 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude 
mixture was treated with sodium borohydride (17.9 mg, 0.474 mmol) and allowed to react 
for 20 minutes. The reaction was quenched with Amberlyst-21.  The crude mixture was then 
purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01, v/v) 
to afford the title compound as a clear, pale yellow oil. 1.59:1ds (136 mg, 78%). (Major) 
1
H 
NMR (400MHz, CDCl3) δ=1.39 (s, 3H), 2.31 (s, 3H), 2.82-2.79 (d, J=10.53 Hz, 1H), 3.06-
3.03 (d, J=10.53 Hz, 1H), 4.99 (s, 1H), 5.06-5.03 (dd, J= 10.99 Hz, 1.37 Hz, 1H), 5.26 (s, 
1H), 5.30-5.25 (dd, J= 17.40 Hz, 1.37 Hz, 1H), 6.00-5.93 (dd, J= 17.40 Hz, 10.99 Hz, 1H), 
7.39-7.08 (m, 14H) (Minor) 
1
H NMR (400MHz, CDCl3) δ=1.33 (s, 3H), 2.31(s, 3H), 2.51-
2.49 (d, J=9.62 Hz, 1H), 3.27-3.25 (d, J=9.62 Hz, 1H), 4.85 (s, 1H), 5.09 (s, 1H), 5.10 – 5.07 
(dd, J=10.99 Hz, 0.92 Hz, 1H), 5.27-5.23 (dd, J=17.40 Hz, 1.37 Hz, 1H), 6.15-6.08 (dd, 
J=17.40 Hz, 10.53 Hz, 1H), 7.39-7.08 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=19.19, 
21.08, 26.89, 36.90, 59.13, 68.35, 80.31, 80.71, 95.02, 112.30, 126.88, 127.22, 127.78, 
128.00, 128.22, 128.31, 128.43, 128.52, 128.87, 128.94, 128.52, 136.68, 137.84, 141.32, 
142.65, 143.95. DART HRMS calcd for C26H27NO [M + H]
+ 
369.21; found 370.217089. 
3-benzhydryl-5-methyl-2-(3-methylphenyl)-5-vinyloxazolidine [65] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (122 mg, 0.456 mmol) and m-tolualdehyde (110 mg, 
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0.912 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude 
mixture was treated with sodium borohydride (16.0 mg, 0.456 mmol) and allowed to react 
for 20 minutes. The reaction was quenched with Amberlyst-21.  The crude mixture was then 
purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01, v/v) 
to afford the title compound as a clear, pale yellow oil. 1.60:1 ds (135 mg, 80%). (Major) 
1
H 
NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.30 (s, 3H), 2.82-2.80 (d, J= 10.99 Hz, 1H), 3.08-
3.05 (d, J=10.99 Hz, 1H), 4.97 (s, 1H), 5.07-5.04 (dd, J= 10.99 Hz, 1.37 Hz, 1H), 5.24 (s, 
1H), 5.31-5.26 (dd, J=17.40 Hz, 1.37 Hz, 1H) 6.00-5.93 (dd, 17.40 Hz, 10.53 Hz, 1H), 7.36-
7.03 (m, 14H). (Minor) 
1
H NMR (400MHz, CDCl3) δ=1.34 (s, 3H), 2.29 (s, 3H), 2.53-2.50 
(d, J= 10.07 Hz, 1H) 3.28-3.26 (d, J=10.07 Hz, 1H), 4.83 (s, 1H), 5.09 (s, 1H), 5.11-5.08 (dd, 
J=10.99 Hz, 1.37 Hz, 1H), 5.26-5.22 (dd, J- 17.40 Hz, 1.37 Hz, 1H), 5.24 (s, 1H), 6.16-6.09 
(dd, J=17.40 Hz, 10.53 Hz, 1H), 7.36 – 7.03 (m, 14H). 13C NMR (100MHz, CDCl3) δ= 
21.52, 25.45, 27.08, 29.72, 53.29, 58.78, 59.49, 67.23, 68.90, 80.55, 80.73, 94.99, 95.44, 
112.35, 112.47, 124.86, 125.59, 126.78, 126.90, 127.21, 127.36, 127.95, 128.02, 128.06, 
128.15, 128.34, 128.45, 128.63, 128.76, 128.88, 129.32, 137.58, 137.63, 139.54, 139.77, 
140.73, 141.55, 142.04, 142.59, 143.84, 143.91. DART HRMS calcd for C26H27NO [M + H]
+ 
369.21; found 370.22330. 
3-benzhydryl-5-methyl-2-(4-chlorophenyl)-5-vinyloxazolidine [66] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (123 mg, 0.459 mmol) and 4-chlorobenzaldehyde (129 
mg, 0.918 mmol). The vial was sealed with a reusable cap and then placed into the 
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microwave reactor.  The reaction was carried out with the following input parameters: 300 
watts, 200 psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The 
crude mixture was treated with sodium borohydride (17.3 mg, 0.459 mmol) and allowed to 
react for 20 minutes. The reaction was quenched with Amberlyst-21.  The crude mixture was 
then purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01, 
v/v) to afford the title compound as a clear, pale yellow oil. 2.90:1 ds (135 mg, 80%). 
(Major) 
1
H NMR (400MHz, CDCl3) δ=1.36 (s, 3H), 2.88-2.85 (d, J=10.99 Hz, 1H), 3.06-
3.03 (d, J=10.99 Hz, 1H), 4.96 (s, 1H), 5.08-5.07 (m, 1H), 5.28 (s, 1H), 5.32-5.29 (m, 1H), 
6.01-5.94 (dd, J=10.53 Hz, 17.40 Hz, 1H), 7.38-7.07 (m, 14H). (Minor) 
1
H NMR (400MHz, 
CDCl3) δ=1.36 (s, 3H), 2.58-2.55 (d, J=10.07 Hz, 1H), 3.30-3.28 (d, J=10.07 Hz, 1H), 4.78 
(s, 1H), 5.10-5.07 (m, 1H), 5.12, (s, 1H), 5.24-5.20 (m, 1H), 6.11-6.04 (dd, J=17.40 Hz, 
10.99 Hz, 1H), 7.38-7.07 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=25.80, 27.20, 59.59, 
60.15, 68.73, 69.94, 80.93, 81.35, 94.32, 94.93, 112.63, 112.77, 127.11, 127.23, 127.39, 
127.55, 128.15, 128.31, 128.39, 128.47, 128.60, 128.96, 128.26, 129.95, 133.84, 134.13, 
138.76, 139.84, 140.35, 141.78, 142.00, 142.47, 143.74, 143.80. DART HRMS calcd for 
C25H24ClNO [M + H]
+ 
389.15; found 390.16519 
3-benzhydryl-5-methyl-2-(3-chlorophenyl)-5-vinyloxazolidine [67] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (120 mg, 0.448 mmol) and 3-chlorobenzaldehyde (126 
mg, 0.896 mmol). The vial was sealed with a reusable cap and then placed into the 
microwave reactor.  The reaction was carried out with the following input parameters: 300 
watts, 200 psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The 
crude mixture was treated with sodium borohydride (16.9 mg, 0.448 mmol) and allowed to 
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react for 20 minutes. The reaction was quenched with Amberlyst-21.  The crude mixture was 
then purified via flash column chromatography using hexanes/ethyl acetate /TEA (95:5:0.01, 
v/v) to afford the title compound as a clear, pale yellow oil. 1.66:1 ds (156 mg, 90%). 
(Major) 
1
H NMR (400MHz, CDCl3) δ= 1.37 (s, 3H), 2.90 – 2.88 (d, J=10.53 Hz, 1H), 3.07-
3.04 (d, J= 10.53 Hz, 1H), 4.96 (s, 1H), 5.11-5.08 (dd, J= 10.53 Hz, 1.83 Hz, 1H), 5.27 (s, 
1H), 5.33-5.27 (dd, J=17.40 Hz, 1.37 Hz, 1H), 6.01-5.94 (dd, J=17.40 Hz, 10.53 Hz, 1H), 
7.41-7.06 (m, 14). (Minor) 
1
H NMR (400MHz, CDCl3) δ=1.37 (s, 3H), 2.60-2.58 (d, J=10.07 
Hz, 1H), 3.32-3.29 (d, J=10.07 Hz, 1H), 4.78 (s, 1H), 5.11-5.08 (dd, J=10.53 Hz, 1.37 Hz, 
1H), 5.12 (s, 1H), 5.24-5.20 (dd, J= 17.40 Hz, 1.37 Hz, 1H), 6.11-6.04 (dd, J= 17.40 Hz, 
10.53 Hz, 1H), 7.41-7.06 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ= 25.45, 27.48, 60.01, 
60.27, 69.33, 70.29, 80.77, 81.39, 94.64, 94.96, 112.56, 112.75, 125.96, 126.60, 127.13, 
127.24, 127.29, 127.45, 127.87, 128.07, 128.10, 128.13, 128.29, 128.44, 128.56, 128.62, 
128.71, 129.32, 130.07, 132.48, 133.88, 133.94, 140.65, 141.68, 142.14, 142.30, 142.41, 
143.53, 143.70. DART HRMS calcd for C25H24ClNO [M + H]
+ 
389.15; found 390.16580 
3-benzhydryl-5-methyl-2-(4-nitrophenyl)-5-vinyloxazolidine [68] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (131mg, 0.489 mmol) and 4-nitrobenzaldehyde (148 mg, 
0.978 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The crude product 
was purified via flash column chromatography using hexanes/ethyl acetate (95:5, v/v) to 
afford the title compound as a clear, pale yellow oil. 1.84:1 ds (160 mg, 82%). (Major) 
1
H 
NMR (400MHz, CDCl3) δ=1.34 (s,3H), 2.97(d, J=10.99 Hz, 1H), 3.06(d, J=11.45 Hz, 1H), 
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4.97 (s,1H), 5.14-5.11(dd, J=10.99 Hz, 1.37 Hz, 1H), 5.36-5.31(dd, J=17.40 Hz, 0.92 Hz, 
1H), 5.38 (s, 1H), 6.02-5.98 (dd, J=16.94 Hz,10.99 Hz, 1H), 7.08-7.02 (m, 3H), 7.27-7.20 
(m, 3H), 7.33-7.27 (m, 2H), 7.44-7.42 (m, 2H), 7.53-7.51 (m, 2H), 8.07-8.04 (m, 2H). 
(Minor) 
1
H NMR (400MHz, CDCl3) δ=1.41(s, 3H), 2.69-2.67(d, J=10.07 Hz, 1H), 3.38-
3.35(d, J=10.53 Hz, 1H), 4.75 (s, 1H), 5.11-5.08 (d, J=0.92 Hz, 10.99 Hz, 1H), 5.22-5.18 (d, 
J=0.92 Hz, 17.40 Hz, 1H), 5.27 (s, 1H), 6.08-6.01 (dd, J=10.99 Hz, 16.49 Hz, 1H), 7.00 (m, 
2H), 7.17 (m, 2H), 7.27-7.24 (m, 2H), 7.39-7.37 (m, 3H), 7.47-7.45 (m, 2H), 7.81-7.79 (d, 
J=6.87 Hz, 1H), 8.02-8.00 (d, J=8.70 Hz, 2H).  
13
C NMR (100MHz, CDCl3) δ=25.87, 27.07, 
61.05, 61.35, 71.08, 71.32, 81.55, 81.92, 94.83, 112.87, 112.99, 123.09, 123.19, 127.41, 
127.47, 127.55, 127.91, 128.15, 128.26, 128.30, 128.40, 128.54, 128.75, 129.21, 130.14, 
141.39, 141.49, 142.16, 142.47, 143.20, 143.43, 147.59, 147.65, 148.05, 149.06. DART 
HRMS calcd for C25H24N2O3 [M + H]
+
 400.18; found 401.186518      
3-benzhydryl-5-methyl-2-(3-nitrophenyl)-5-vinyloxazolidine [69] 
 
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube 
was charged with amino alcohol 60 (145 mg, 0.542 mmol) and 3-nitrobenzaldehyde (164 mg, 
1.09 mmol). The vial was sealed with a reusable cap and then placed into the microwave 
reactor.  The reaction was carried out with the following input parameters: 300 watts, 200 
psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The crude product 
was purified via flash column chromatography using hexanes/ethyl acetate (80:20, v/v) to 
afford the title compound as a clear, pale yellow oil. 2.09:1 ds (152 mg, 71%). (Major) 
1
H 
NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.94-2.91 (d, J=10.99 Hz, 1H), 3.13-3.10 (d, 
J=10.99 Hz, 1H), 4.92 (s, 1H), 5.14-5.11 (m, 1H), 5.36-5.35 (m, 1H), 5.39 (s, 1H), 6.02-5.95 
(dd, J=17.40 Hz, 10.53 Hz, 1H), 7.02-6.96 (m, 2H), 7.23-7.19 (m, 3H), 7.35-7.26 (m, 3H), 
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7.47-7.39 (m, 2H), 7.68-7.66 (m, 1H), 7.80-7.78 (m, 1H), 8.01-7.99 (m, 1H), 8.12 (s, 1H) 
(Minor) 
1
H NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.67-2.64 (d, J=10.07 Hz),3.40-3.38 (d, 
J=10.07 Hz, 1H), 4.71 (s, 1H), 5.25-5.20 (m, 1H), 5.24 (s, 1H), 5.36-5.31 (m, 1H), 6.12-6.05 
(dd, J=17.40 Hz, 10.53 Hz, 1H), 6.97-6.93 (m, 3H), 7.15-7.13 (m, 3H),7.28-7.23 (m, 2H) 
7.44-7.39, (m, 2H),7.57-7.54 (m, 1H), 7.65-7.63 (m, 1H), 7.99- 7.96 (m, 1H), 8.05 (s, 1H). 
13
C NMR (100MHz, CDCl3) δ=27.03, 61.08, 71.25, 81.39, 94.31, 112.73, 122.86, 122.93, 
127.36, 127.39, 127.86, 128.29, 128.33, 128.76, 133.89, 141.79, 142.43, 143.20, 143.98, 
148.02. DART HRMS calcd for C25H24N2O3 [M + H]
+
 400.18; found 401.18240  
1-(1-benzhydryl-5-ethyl-pyrrolidin-3-yl)ethanone [48] 
 
According to the general procedure, oxazolidine 47 (75 mg, 0.246 mmol) 
and BF3•OEt2 (8.7 mg, 0.062 mmol) were reacted for 15 minutes. The general workup 
afforded the title compound as a pale yellow oil (67 mg, 88%). 
1
H NMR (400MHz, CDCl3) 
δ= 0.75 (t, J=7,3 Hz, 3H), 1.19 (m, 1H), 1.43 (m, 1H), 1.73 (m, 1H), 2.09 (m, 1H), 2.10 (s, 
3H), 2.49 (dd, J=9.2, 7.8 Hz, 1H), 2.80 (sept, J=4.6 Hz, 1H), 3.05 (m, 2H), 4.78 (s, 1H), 7.25 
(m, 10H). 
13
C NMR (100MHz, CDCl3) δ= 10.4, 25.2, 29.0, 31.5, 49.8, 52.3, 62.0, 70.0, 126.9 
127.0, 128.1, 128.2, 128.3, 128.8, 141.5, 143.6, 209.6. DART HRMS calcd for C21H25NO [M 
+ H]
+
 307.19; found 308.20861 
1-(1-benzhydryl-5-phenyl-pyrrolidin-3-yl)ethanone [50] 
 
According to the general procedure, oxazolidine 49 (47 mg, 0.132 mmol) 
and BF3•OEt2 (4.7 mg, 0.033 mmol) were reacted for 15 minutes. The general workup 
afforded the title compound as a pale yellow oil (41 mg, 87%). 
1
H NMR (400MHz, CDCl3) 
δ= 1.92-1.84 (m, 1H), 2.08 (s, 3H), 2.42-2.36 (m, 2H), 3.37-3.27 (m, 2H), 3.68-3.64 (m, 1H), 
4.80 (s, 1H), 7.40-7.06 (m, 15). 
13
C NMR (100MHz, CDCl3) δ= 29.21, 36.60, 49.40, 50.62, 
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64.47, 67.13, 126.62, 127.04, 127.28, 127.47, 127.88, 128.13, 128.54, 129.91, 138.44, 
142.27, 143.96, 208.90. DART HRMS calcd for C25H25NO [M + H]
+
 355.19; found 
356.21197 
 1-(1-benzhydryl-5-(4-methoxyphenyl)pyrrolidin-3-yl)ethanone [70] 
 
According to the general procedure, oxazolidine 62 (118 mg, 0.307 mmol) 
and BF3•OEt2 (10.9 mg, 0.077 mmol) were reacted for 12 hours. The general workup 
afforded the title compound as a pale yellow oil (103 mg, 96%). 
1
H NMR (400MHz, CDCl3) 
δ=1.93-1.86 (m, 1H), 2.10 (s, 3H), 2.42-2.35 (m, 2H), 3.38-3.28 (m, 2H), 3.65-3.61 (m, 1H), 
3.79 (s, 3H), 4.83 (s, 1H), 6.86-6.85 (m, 2H), 7.36-7.14 (m, 12H). 
13
C NMR (100MHz, 
CDCl3) δ=29.08, 29.60, 36.30, 49.31, 50.42, 55.06, 64.35, 67.01, 112.23, 112.79, 119.72, 
126.49, 127.16, 127.76, 127.94, 128.00, 129.38, 129.77M 138.29, 142.18, 145.63, 159.70, 
208.65. DART HRMS calcd for C26H27NO2 [M + H]
+ 
385.12; found 386.21249    
 1-(1-benzhydryl-5-(3-methoxyphenyl)pyrrolidin-3-yl)ethanone [71] 
 
According to the general procedure, oxazolidine 63 (28 mg, 0.74 mmol) 
and BF3•OEt2 (2.6 mg, 0.019 mmol) were reacted for 12 hours. The general workup afforded 
the title compound as a pale yellow oil (23 mg, 82%). 
1
H NMR (400MHz, CDCl3) δ=1.93-
1.85 (m, 1H), 2.09 (s, 3H), 2.42-2.35 (m, 2H) 3.35-3.27 (m, 2H), 3.67-3.63 (m, 1H), 3.78 (s, 
3H), 4.83 (s, 1H), 6.76 (m, 1H), 6.94-6.91 (m, 2H), 7.34-7.14 (m, 11H). 
13
C NMR (100MHz, 
CDCl3) δ=29.08, 29.64, 36.30, 49.31, 50.42, 55.06, 64.35, 67.01, 76.67, 77.00, 77.31, 
112.23, 112.79, 119.72, 126.49, 127.16, 127.76, 127.94, 128.00, 129.38, 129.77, 138.29, 
142.18, 145.63, 159.70, 208.65 DART HRMS calcd for C26H27NO2 [M + H]
+ 
385.12; found 
386.21202 
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1-(1-benzhydryl-5-(p-tolyl)pyrrolidin-3-yl)ethanone [72] 
 
According to the general procedure, oxazolidine 64 (35 mg, 0.094 mmol) 
and BF3•OEt2 (3.3 mg, 0.024 mmol) were reacted for 60 minutes. The general workup 
afforded the title compound as a pale yellow oil (28 mg, 80%). 
1
H NMR (400MHz, CDCl3) 
δ= 1.91-1.84 (m, 1H), 2.08 (s, 3H), 2.32 (s, 3H), 2.40-2.32 (m, 2H), 3.35-3.26 (m, 2H), 3.63-
3.60 (m, 1H), 4.81 (s, 1H), 7.35-7.10 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=21.54, 29.08, 
36.36, 49.33, 50.49, 64.47, 66.84, 124.40, 126.45, 127.15, 127.70, 127.74, 127.99, 128.16, 
128.33, 129.83, 137.88, 138.32, 142.29, 143.69, 208.67. DART HRMS calcd for C26H27NO 
[M + H]
+ 
369.21; found 370.21320 
1-(1-benzhydryl-5-(m-tolyl)pyrrolidin-3-yl)ethanone [73] 
 
According to the general procedure, oxazolidine 65 (19 mg, 0.052 mmol) 
and BF3•OEt2 (1.8 mg, 0.013 mmol) were reacted for 60 minutes. The general workup 
afforded the title compound as a pale yellow oil (16 mg, 85%). 
1
H NMR (400MHz, CDCl3) 
δ=1.93-1.85 (m, 1H), 2.08 (s, 3H), 2.31 (s, 3H), 2.41-2.31 (m, 2H), 3.36-3.29 (m, 2H), 3.64-
3.61 (m, 1H), 4.80 (s, 1H), 7.33-7.02 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=21.41, 29.10, 
36.50, 49.38, 50.38, 64.40, 66.88, 124.40, 126.46, 127.03, 127.71, 128.00, 128.16, 128.28, 
129.84, 137.89, 142.33, 143.72, 208.83. DART HRMS calcd for C26H27NO [M + H]
+ 
369.21; 
found 370.21310 
1-(1-benzhydryl-5-(4-chlorophenyl)pyrrolidin-3-yl)ethanone [74]  
 
According to the general procedure, oxazolidine 66 (38 mg, 0.104 mmol) 
and BF3•OEt2 (3.7 mg, 0.026 mmol) were reacted for 60 minutes. The general workup 
afforded the title compound as a pale yellow oil (32 mg, 88%). 
1
H NMR (400MHz, CDCl3) 
δ= 1.87-1.79 (m, 1H), 2.10 (s, 3H), 2.44-2.37 (m, 2H), 3.26 (m, 2H), 3.68-3.64 (m, 1H), 4.75 
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(s, 1H), 7.34-7.12 (m, 14H). 
13
C NMR (100MHz, CDCl3) δ=24.54, 31.93, 44.62, 46.51, 
59.39, 63.29, 122.06, 122.66, 123.23, 123.42, 123.53, 123.92, 124.02, 124.90, 127.81, 
134.06, 137.37, 138.00, 204.48. DART HRMS calcd for C25H24ClNO [M + H]
+ 
389.15; 
found 390.16019 
 1-(1-benzhydryl-5-(3-chlorophenyl)pyrrolidin-3-yl)ethanone [75] 
 
According to the general procedure, oxazolidine 67 (62 mg, 0.159 mmol) 
and BF3•OEt2 (5.6 mg, 0.040 mmol) were reacted for 60 minutes. The general workup 
afforded the title compound as a pale yellow oil (54 mg, 85%). 
1
H NMR (400MHz, CDCl3) 
δ=1.88-1.81 (m, 1H), 2.08 (s, 3H), 2.46-2.37 (m, 1H), 3.39-3.26 (m, 2H), 3.70 – 3.66 (m, 
1H), 4.73 (s, 1H), 7.34-7.09 (m, 14H).  
13
C NMR (100MHz, CDCl3) δ=29.70, 37.19, 49.64, 
52.11, 64.83, 69.29, 125.87, 127.22, 127.41, 127.73, 127.82, 128.28, 128.62, 128.68, 129.80, 
130.08, 124.57, 139.53, 142.37, 147.12, 209.37. DART HRMS calcd for C25H24ClNO [M + 
H]
+ 
389.15; found 390.15530 
1-(1-benzhydryl-5-(4-nitrophenyl)pyrrolidin-3-yl)ethanone [76] 
 
According to the general procedure, oxazolidine 68 (92 mg, 0.230 mmol) 
and BF3•OEt2 (8.2 mg, 0.058 mmol) were reacted for 16 hours. The general workup afforded 
the title compound as a pale yellow oil 18:1 ds (80 mg, 87%). (Major) 
1
H NMR (400MHz, 
CDCl3) δ= 1.85-1.78 (m, 1H), 2.11 (s, 3H), 2.54-2.45 (m, 2H), 3.37-3.29 (m, 1H), 3.46-3.43 
(m, 1H), 4.70 (s, 1H), 7.04-7.02 (m, 3H), 7.19-7.16 (m, 2H), 7.26-7.24 (m, 3H), 7.33-7.30 
(m, 2H), 7.38-7.36 (m, 2H), 8.05-8.03 (m, 2H). (Minor) 
 1
H NMR (400MHz, CDCl3) δ= 
0.85-1.78 (m, 1H), 2.20 (s, 3H), 3.00-2.94 (m, 2H),3.46-3.29 (m, 1H), 3.69-3.65 (m, 1H), 
4.70 (s, 1H), 7.19-7.16 (m, 1H), 7.26-7.24 (m, 3H), 7.36-7.31 (m, 3H), 7.49-7.44 (m, 3H), 
7.59-7.55 (m, 1H), 7.80-7.78 (m, 2H), 8.10-8.05 (m, 1H). 
13
C NMR (100MHz, CDCl3) 
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δ=29.32, 36.95, 49.48, 53.13, 64.74, 70.61, 123.51, 126.98, 127.36, 127.80, 127.84, 128.36, 
128.81, 139.84, 141.59, 146.66, 152.78, 208.73.  DART HRMS calcd for C25H24N2O3 [M + 
H]
+
 400.18; found 401.18420    
 1-(1-benzhydryl-5-(3-nitrophenyl)pyrrolidin-3-yl)ethanone [77] 
 
According to the general procedure, oxazolidine 69 (105 mg, 0.261 mmol) 
and BF3•OEt2 (9.3 mg, 0.065 mmol) were reacted for 15 minutes. The general workup 
afforded the title compound as a pale yellow oil 17:1ds (95 mg, 90%). (Major) 
1
H NMR 
(400MHz, CDCl3) δ=1.89-1.82 (m, 1H), 2.11 (s, 3H), 2.59-2.47 (m, 2H), 3.40-3.30 (m, 1H), 
3.49-3.45 (m, 1H), 3.88-3.84 (m, 1H), 4.69 (s, 1H), 7.00-6.98 (m, 3H), 7.17 (m, 2H), 7.24 
(m, 1H), 7.33-7.29 (m, 5H) 7.50-7.46 (m, 1H), 7.97 – 7.94 (m, 1H), 8.06-8.04 (m, 1H). 
(Minor) 
1
H NMR (400MHz, CDCl3) δ=1.65 (m, 1H), 2.21 (s, 3H), 2.36-2.27 (m, 2H), 2.71-
2.59 (m, 1H), 3.01-2.92 (m, 1H), 3.47-3.45 (m, 1H), 3.71-3.67 (m, 1H), 7.33-6.98 (m, 5H), 
7.59-7.55 (m, 6H), 7.75-7.73 (m, 1H), 8.02-7.96 (m, 2H). 
13
C NMR (100MHz, CDCl3) 
δ=29.43, 37.15, 49.46, 53.66, 64.76, 71.46, 121.68, 122.29, 127.02, 127.43, 127.92, 128.38, 
128.53, 128.75, 129.13, 129.53, 130.14, 132.44, 133.38, 140.48, 141.70, 147.58, 148.30, 
208.21. DART HRMS calcd for C25H24N2O3 [M + H]
+
 400.18; found 401.18240    
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